Order Article Reprints

Vyas P, Khoury ES, Sah N, Sharma A, Allende Labastida J, Wilkinson EL, Lac K, Damiba NNL, Fowler A, Liu J, et al. Dendrimer-Conjugated Glutamine Antagonist, D-TTM020, Ameliorates Brain Immune Dysregulation and Improves Neurobehavioral Deficits in the Mecp2-Deficient Mouse Model. Cells. 2026; 15(3):272. https://doi.org/10.3390/cells15030272

Vyas, Preeti, Elizabeth Smith Khoury, Nirnath Sah, Anjali Sharma, Javier Allende Labastida, Elizabeth L. Wilkinson, Kathleen Lac, Nerketa N. L. Damiba, Amanda Fowler, Jinhuan Liu, and et al. 2026. "Dendrimer-Conjugated Glutamine Antagonist, D-TTM020, Ameliorates Brain Immune Dysregulation and Improves Neurobehavioral Deficits in the Mecp2-Deficient Mouse Model" Cells 15, no. 3: 272. https://doi.org/10.3390/cells15030272

Vyas, P., Khoury, E. S., Sah, N., Sharma, A., Allende Labastida, J., Wilkinson, E. L., Lac, K., Damiba, N. N. L., Fowler, A., Liu, J., Bedner, A., Majer, P., Tichý, T., Thomas, A. G., Rais, R., Slusher, B. S., Kannan, R. M., & Kannan, S. (2026). Dendrimer-Conjugated Glutamine Antagonist, D-TTM020, Ameliorates Brain Immune Dysregulation and Improves Neurobehavioral Deficits in the Mecp2-Deficient Mouse Model. Cells, 15(3), 272. https://doi.org/10.3390/cells15030272